The University of Michigan has received FDA approval for a new type of liver cancer treatment.
Sound waves could now be used to break down liver cancer tumors. The treatment is called histotripsy and has potential to become a non-invasive alternative to chemotherapy.
Last week, the technique received FDA approval.
Mishal Mendiratta-Lala is a professor of radiology with Michigan Medicine and worked on the clinical trials. She says her trials have shown encouraging results.
“It’s very exciting that even in my clinical trials that I had, we have patients that are two years after treatment without recurrence of the tumor that we treated. So, it’s a very exciting time for cancer therapy.”
Currently, the treatment is only approved to treat liver tumors.
Non-commercial, fact based reporting is made possible by your financial support. Make your donation to WEMU todayto keep your community NPR station thriving.
Like 89.1 WEMU on Facebook and follow us on Twitter
Contact WEMU News at 734.487.3363 or email us at studio@wemu.org
